Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
3% from low
Exchange
OTC Link
CS
FIFTY 1 LABS INC
No one on the platform currently holds FITY.
No tracked institution reports a position in FITY as of their last filing.
No one on the platform has traded FITY yet.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| FITYFifty 1 Labs, Inc. | $0.00 | +16.67% | $200158 | — |
| AIJTYJianpu Technology Inc. | $0.87 | +3.08% | $871139 | — |
| ATNPQAtlantis Technology Group | $0.00 | +0.00% | $925827 | — |
| CNERBioEnergy Development Inc. | $0.01 | +0.00% | $51M | — |
| CSOLChina Solar & Clean Energy Solutions, Inc. | $0.01 | +0.00% | $496548 | — |
| FNNZFFinCanna Capital Corp. | $0.00 | +0.00% | $3M | — |
| IHAIInnovative Holdings Alliance, Inc. | $0.12 | -4.12% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$FITY what does Fity need to get out of trips?? We get to .0007 - .0008 then back down to .0003- .0004. What will it take to break us out?
View on StockTwits ↗$FITY big volume Friday! Picked up 1.2 mil shares… is this the beginning of the upward trend? Hits 4 again going for another 500k in shares! They are all 1.5 years into their no pay contract to make it a $50 mil evaluation to get paid! Things should start to change very soon
View on StockTwits ↗$FITY they need to buyback more shares and this will go to double zeros
View on StockTwits ↗$FITY Strategic Core & Focus AreasFifty 1 Labs announced a strategic shift to position itself as a peptide biotechnology and telehealth company. The strategy focuses primarily on:Musculoskeletal (MSK) Health & Recovery: Targeting tissue healing, injury rehabilitation, post-surgical recovery, and sports performance.Target Compounds: Planning research and commercial pathways around known investigational peptides such as BPC-157, TB-500, MOTS-c, and Sermorelin, alongside novel peptide analogues.AI Integration: Utilizing AI-assisted discovery workflows (in silico candidate generation, pathway mapping) to streamline candidate selection and formulation development.
View on StockTwits ↗$IGPK $AEFI $AMFN $FITY everyone wants a runner but who’s gonna help to fight to make it happen? We can see how the MM’s do things, weather fight or fold, GLTY.
View on StockTwits ↗$FITY this one may actually have legs…I’m gonna hold my 16m for a while. At least 7 of the recent people added to the panel are in favor of r&d, trials, and adding to the pharmacy compounding list. Psilocybin was fast tracked, might be the same case here.
View on StockTwits ↗$FITY https://www.washingtonpost.com/health/2026/07/23/fda-advisory-panel-vote-recommending-7-peptides-broader-access/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.